Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Stage IB Lung Non-Small Cell Carcinoma AJCC v7 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT05445310

Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung Cancer

This is a prospective, single arm study to investigate the efficacy and safety furmonertinib 80mg/d as adjuvant treatment for 3 years post surgery of stage IA w…

China114 participantsStarted 2022-08-06

Treatment: Furmonertinib

All recent trials (55 shown)

Active — Not RecruitingNot Applicable

NCT02194738

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by…

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. St…

United States8,300 participantsStarted 2014-09-26

Treatment: Biospecimen Collection, Carboplatin

Active — Not RecruitingPhase 3

NCT02193282

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Remo…

This phase III ALCHEMIST trial studies how well erlotinib hydrochloride compared to observation works in treating patients with stage IB-IIIA non-small cell lun…

United States390 participantsStarted 2015-02-11

Treatment: Clinical Observation, Erlotinib Hydrochloride

Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung Cancer

All recent trials (55 shown)

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by…

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Remo…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung Cancer

All recent trials (55 shown)

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by…

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Remo…

Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIS…

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-sma…

Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cance…

Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery

Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK F…

Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-smal…

Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung…

Icotinib for Completed Resected IB NSCLC With EGFR Mutation

Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Follo…

Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-sma…

SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Can…

Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy

Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer